Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E
- PMID: 12821659
- DOI: 10.1074/jbc.M305593200
Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E
Abstract
The nonclassical major histocompatibility complex class I molecule HLA-E acts as a ligand for CD94/NKG2 receptors on the surface of natural killer cells and a subset of T cells. HLA-E presents closely related nonameric peptide epitopes derived from the highly conserved signal sequences of classical major histocompatibility complex class I molecules as well as HLA-G. Their generation requires cleavage of the signal sequence by signal peptidase followed by the intramembrane-cleaving aspartic protease, signal peptide peptidase. In this study, we have assessed the subsequent proteolytic requirements leading to generation of the nonameric HLA-E peptide epitopes. We show that proteasome activity is required for further processing of the peptide generated by signal peptide peptidase. This constitutes the first example of capture of a naturally derived short peptide by the proteasome, producing a class I peptide ligand.
Similar articles
-
Proteasomes can either generate or destroy MHC class I epitopes: evidence for nonproteasomal epitope generation in the cytosol.J Immunol. 1998 Jul 1;161(1):112-21. J Immunol. 1998. PMID: 9647214
-
Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors.J Immunol. 2001 Aug 1;167(3):1212-21. doi: 10.4049/jimmunol.167.3.1212. J Immunol. 2001. PMID: 11466336
-
The effect of the proteasome inhibitor lactacystin on the presentation of transporter associated with antigen processing (TAP)-dependent and TAP-independent peptide epitopes by class I molecules.J Immunol. 1997 Sep 1;159(5):2139-46. J Immunol. 1997. PMID: 9278300
-
Proteolysis and class I major histocompatibility complex antigen presentation.Immunol Rev. 1999 Dec;172:49-66. doi: 10.1111/j.1600-065x.1999.tb01355.x. Immunol Rev. 1999. PMID: 10631936 Review.
-
HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells.Curr Pharm Des. 2009;15(28):3336-44. doi: 10.2174/138161209789105207. Curr Pharm Des. 2009. PMID: 19860683 Review.
Cited by
-
The emerging role of HLA-E-restricted CD8+ T lymphocytes in the adaptive immune response to pathogens and tumors.J Biomed Biotechnol. 2010;2010:907092. doi: 10.1155/2010/907092. Epub 2010 Jun 22. J Biomed Biotechnol. 2010. PMID: 20634877 Free PMC article. Review.
-
Antigen presentation by MHC-E: a putative target for vaccination?Trends Immunol. 2022 May;43(5):355-365. doi: 10.1016/j.it.2022.03.002. Epub 2022 Mar 31. Trends Immunol. 2022. PMID: 35370095 Free PMC article. Review.
-
Regulation of the cell surface expression of classical and non-classical MHC proteins by the human cytomegalovirus UL40 and rhesus cytomegalovirus Rh67 proteins.J Virol. 2024 Sep 17;98(9):e0120624. doi: 10.1128/jvi.01206-24. Epub 2024 Aug 29. J Virol. 2024. PMID: 39207137 Free PMC article.
-
Transmembrane Helices Are an Overlooked Source of Major Histocompatibility Complex Class I Epitopes.Front Immunol. 2017 Sep 11;8:1118. doi: 10.3389/fimmu.2017.01118. eCollection 2017. Front Immunol. 2017. PMID: 28959259 Free PMC article.
-
Diverse roles of non-diverse molecules: MHC class Ib molecules in host defense and control of autoimmunity.Curr Opin Immunol. 2011 Feb;23(1):104-10. doi: 10.1016/j.coi.2010.09.009. Epub 2010 Oct 21. Curr Opin Immunol. 2011. PMID: 20970974 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials